Navigation Links
Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma
Date:11/12/2007

tudy is available at http://www.allos.com or the U.S. government's clinical trials database at http://www.clinicaltrials.gov.

About Non-Hodgkin's Lymphoma

Non-Hodgkin's lymphoma (NHL) is the most common hematological cancer and the fifth leading cause of cancer death in the U.S. An estimated 63,000 new cases of NHL will be diagnosed each year, of which peripheral T-cell lymphoma represents approximately 10 percent.

About Allos Therapeutics, Inc.

Allos Therapeutics, Inc. (ALTH) is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer. The Company's lead product candidate, PDX (pralatrexate), is a novel antifolate currently under evaluation in a pivotal Phase 2 (PROPEL) trial in patients with relapsed or refractory peripheral T-cell lymphoma. The PROPEL trial is being conducted under an agreement reached with the U.S. Food and Drug Administration under its special protocol assessment, or SPA process. The Company is also investigating PDX in patients with non-small cell lung cancer and a range of lymphoma sub-types. The Company's other product candidate is RH1, a targeted chemotherapeutic agent that is currently being evaluated in a Phase 1 study in patients with advanced solid tumors or non-Hodgkin's lymphoma. For additional information, please visit the Company's website at http://www.allos.com.

Safe Harbor Statement

This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements relating to the potential safety and efficacy profile of RH1 for the treatment of advanced solid tumors, non-Hodgkin's lymphoma or any other type of cancer; the potential o
'/>"/>

SOURCE Allos Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
2. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
5. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
8. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
11. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... N.J. , July 30, 2014 Stryker brand ambassadors ... this week at the 3M Championship Champions Tour event near ... Cities, in Blaine . Stryker is the official ... Starting Friday, August 1 st through Sunday, ... Stryker Mobility Zone; an on-site joint health destination located in the ...
(Date:7/30/2014)... 2014 Silicon Valley Bank, the bank of ... that examines the merger, acquisition and IPO activity ... to the annual report based on 2013 data, venture ... SVB started tracking the data in 2005. ... solid healthcare M&A activity over the last few years, ...
(Date:7/30/2014)... NEW YORK , July 30, 2014 /PRNewswire/ ... new products for oncology supportive care, announced that its ... been featured in an article on OncLive.com titled, "Study ... and Neck Cancers."  Dr. Steve Sonis , a ... growing demand seen in the oncology community for evidence-based ...
Breaking Medicine Technology:Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 3Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 4Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 5Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3
... TITUSVILLE, N.J., July 24 Ortho-McNeil Neurologics, a,division ... Food and Drug Administration (FDA) has granted pediatric,exclusivity ... to a Written Request by the FDA to ... 1 to 24 months with partial onset seizures., ...
... Oncology Patient Accrual, DENVER, July 24 ... has contracted with five leading pharmaceutical,companies to ... their,clinical trials using the Just-in-Time (JIT) enrollment ... indications: follicular Non-Hodgkin,s,Lymphoma, Metastatic Breast Cancer, Metastatic ...
Cached Medicine Technology:FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 2FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 3Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2
(Date:7/30/2014)... adults is being financially exploited often by their ... affects poor and black people. It merits the scrutiny ... cares about the dignity and well-being of older Americans, ... in the US. She led one of the largest ... which appear in the Journal of General Internal ...
(Date:7/30/2014)... within a large teaching hospital in Ireland has shown than ... in place to minimise the risk of entrapment. The report, ... therefore emphasises the need for careful selection of patients for ... need for monitoring and maintenance of hospital bed systems. , ... falling from bed. However, although the risk for any individual ...
(Date:7/30/2014)... July 30, 2014 The report entitled ... an insight into the market dynamics and changing trends ... the actual and forecasted market sizing of the global ... fuelling the demand of the same. It further captures ... major players in the market. Further, the report discusses ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Los ... comprehensive cosmetic dental treatments that can help patients create ... Dental. Healthy teeth and gums form the foundation of ... smile. While minor chips, misshapen teeth or stains may ... from a smile’s appearance. The right cosmetic treatments can ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Building ENT ... throat, allergy, and audiology practice in Westchester County takes ... state-of-the-art technology, a superb underlying corporate structure and protocols, ... It also takes a leading Chief Financial Officer to ... Journal (WCBJ), that’s exactly what it possesses. In fact, ...
Breaking Medicine News(10 mins):Health News:Older adults are at risk of financial abuse 2Health News:High frequency of potential entrapment gaps in hospital beds 2Health News:Global Pulse Oximetry Market 2018 Opportunities and Trends Now Available at MarketReportsOnline.com 2Health News:Global Pulse Oximetry Market 2018 Opportunities and Trends Now Available at MarketReportsOnline.com 3Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Now Offers Comprehensive Cosmetic Dental Treatments 2Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Now Offers Comprehensive Cosmetic Dental Treatments 3Health News:The Leading Ear, Nose, and Throat Practice in Westchester County Has One of the Leading CFO’s in Westchester County! 2Health News:The Leading Ear, Nose, and Throat Practice in Westchester County Has One of the Leading CFO’s in Westchester County! 3
... Bethesda, MD -- Eliminating polio everywhere will require global ... poor countries to vaccinate with inactivated polio vaccine (IPV), ... Health Affairs thematic issue on global health. ... been achieved by 2000, but the effort to fight ...
... week in the open access journal PLoS Medicine ... in Australia, encouraging the use of pedometers simple step ... and promoting physical activity through mass media campaigns are ... the health benefits they result in. Considered as a package, ...
... , COLUMBUS, Ohio, July 13 With ... which provide around-the-clock care to 80,000 frail elderly and disabled ... meeting increased demand for quality, around-the-clock care with $184 million ... As a result, skilled nursing facilities will have to reduce ...
... 13 The Department of Defense has selected United Health Military ... the South Region. This decision comes at the completion of ... , , (Logo: ... After a Wednesday debriefing from the TRICARE Management Activity, TriServ ...
... modeling of radiation risk suggests that widespread screening for ... tomography scans would lead to an estimated 42 additional ... per 100,000 women, according to a report in the ... , one of the JAMA/Archives journals. Coronary artery ...
... 31 to July 14, a six-man international crew called ... composed of four Russians and two Europeans, simulated a ... scenarios, including emergency situations and 20-minute communications delays. ... teams with experiments evaluating solutions to conditions that impact ...
Cached Medicine News:Health News:Eliminating polio requires global, coordinated effort -- Health Affairs article highlights risks, rewards of eradication 2Health News:Eliminating polio requires global, coordinated effort -- Health Affairs article highlights risks, rewards of eradication 3Health News:Eliminating polio requires global, coordinated effort -- Health Affairs article highlights risks, rewards of eradication 4Health News:Eliminating polio requires global, coordinated effort -- Health Affairs article highlights risks, rewards of eradication 5Health News:What are the most effective ways of promoting physical exercise in adults? 2Health News:What are the most effective ways of promoting physical exercise in adults? 3Health News:State Budget Will Hurt Care in Skilled Nursing Facilities 2Health News:Study estimates radiation dose, cancer risk from coronary artery calcium screening 2Health News:Study estimates radiation dose, cancer risk from coronary artery calcium screening 3Health News:105-day Mars simulation: US studies focus on improving work performance 2Health News:105-day Mars simulation: US studies focus on improving work performance 3Health News:105-day Mars simulation: US studies focus on improving work performance 4
The NOW® Flu B test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results an...
... Genetic Analyzer is an automated single-capillary genetic ... sequencing and fragment analysis applications. An affordable, ... who incorporate genetic analysis into their work., ... alternative to gel-based DNA analysis for any ...
... surgery represents one of the most technically ... Pelvic Plating System offers the highly specialized ... addressing fractures of the pelvis and acetabulum. ... as a premiere pelvic surgeon, is the ...
... The ACE Titanium Small Fragment System has ... surgeon with superior implants and user-friendly instrumentation. ... cannulated screws, and fracture instrumentation is designed ... armamentarium to utilize current and classic techniques ...
Medicine Products: